News

That day, the Twitter account @EliLillyandCo posted ... Eli Lilly accounts had issued their fake insulin tweets, Eli Lilly’s stock share price tumbled by 4.37% or $16.08 down to $352.30 ...
Verve Therapeutics stock nearly doubled Tuesday after Eli Lilly agreed to buy the gene-editing company for up to $1.3 billion ...
I think the stock is a good pick to buy with the recent pullback. Forget last week's Twitter tumult. Lilly is a verified winner. 10 stocks we like better than Eli Lilly and Company When our award ...
Eli Lilly ( LLY 0.90%) is one of the undisputed leaders in the fast-growing market for weight-management medicines. Following ...
Shares of Verve Therapeutics skyrocketed 75% in premarket trading Tuesday after Eli Lilly announced it would acquire the gene-editing startup for about $1.3 billion.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Insulin producer Eli Lilly faces the economic ... producer saw a 4.5 percent drop in its stock and had to issue a clarification on its official Twitter account, @LillyPad. Mashable Trend Report ...
Pharma company Eli Lilly has been criticized heavily in the past for the price of insulin, but the company has claimed it is not profiting off those increases. Photo: Darron Cummings (AP) As much ...
Billionaire Elon Musk’s changes to social media giant Twitter are already costing some companies billions in total stock value. Pharmaceutical company Eli Lilly (LLY) dipped 4.37 per cent Friday ...
Eli Lilly (LLY) stock is higher Thursday after the pharmaceutical company beat profit expectations and matched revenue forecasts for its fourth quarter and issued a better-than-expected outlook ...
Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year.
But is Eli Lilly stock a buy after last week's Twitter prank? A Twitter account calling itself "Eli Lilly and Company" tweeted on Thursday, Nov. 10, 2022, "We are excited to announce insulin is ...